Deardorf Caren — SEC Form 4 filings

SEC reporting owner CIK 1871152. 4 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-06-11 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Crinetics Pharmaceuticals, Inc. (CRNX)Director414

Form 4 filings — Deardorf Caren

FiledFormIssuerReported transactionsSource
2026-09-014Crinetics Pharmaceuticals, Inc. (CRNX)Disposition to issuer (D): 16,300 @ $85 · Disposition to issuer (D): 5,925 @ $85 · Disposition to issuer (D): 35,000 (derivative) @ $65.70 · Disposition to issuer (D): 4,375 (derivative) @ $66.71 · Disposition to issuer (D): 17,500 (derivative) @ $64.68 · Disposition to issuer (D): 12,500 (derivative) @ $40.29 · +2 moreEDGAR
2026-06-224Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 5,925 @ $0 · Grant/award (A): 9,730 (derivative) @ $0EDGAR
2025-06-134Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0EDGAR
2024-06-114Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1871152 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →